1h Free Analyst Time
The digital diabetes management market is forecasted to grow by USD 16.57 billion during 2024-2029, accelerating at a CAGR of 13.6% during the forecast period. The report on the digital diabetes management market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global burden of diabetes, growing awareness of benefits of digital diabetes management, and increasing government support to reduce diabetes.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The digital diabetes management market is segmented as below:
By End-user
- Hospitals
- Home settings
- Diagnostic centers
By Type
- Wearable devices
- Hand-held devices
By Product
- SMBG meters
- Insulin pumps
- CGM devices
- CGM sensors
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the digital diabetes management market covers the following areas:
- Digital Diabetes Management Market sizing
- Digital Diabetes Management Market forecast
- Digital Diabetes Management Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by End-user
9 Market Segmentation by Type
10 Market Segmentation by Product
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global digital diabetes management market: Abbott Laboratories, B.Braun SE, Becton Dickinson and Co., DarioHealth Corp., Dassault Systemes SE, decide Clinical Software GmbH, Dexcom Inc., F. Hoffmann La Roche Ltd., Glooko Inc., GlucoMe Ltd., Informed Data Systems Inc. and One Drop., Insulet Corp., LifeScan IP Holdings LLC, Medtronic PLC, Orpyx Medical Technologies Inc., PHC Holdings Corp., Sharecare Inc., SOCIALDIABETES SL, Tandem Diabetes Care Inc., and WaveForm Technologies Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is integration of AI in wearable medical devices."
According to the report, one of the major drivers for this market is the rising global burden of diabetes.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- B.Braun SE
- Becton Dickinson and Co.
- DarioHealth Corp.
- Dassault Systemes SE
- decide Clinical Software GmbH
- Dexcom Inc.
- F. Hoffmann La Roche Ltd.
- Glooko Inc.
- GlucoMe Ltd.
- Informed Data Systems Inc. and One Drop.
- Insulet Corp.
- LifeScan IP Holdings LLC
- Medtronic Plc
- Orpyx Medical Technologies Inc.
- PHC Holdings Corp.
- Sharecare Inc.
- SOCIALDIABETES SL
- Tandem Diabetes Care Inc.
- WaveForm Technologies Inc.
